Menu

CME Corner

Program Detail

Release Date: March-29-19
Credit Expiration Date: March-29-20

Faculty

Anton Porsteinsson, MD
William B. and Sheila Konar Professor of Psychiatry
University of Rochester School of Medicine and Dentistry
Alzheimer's Disease Care, Research and Education Program (AD-CARE)
University of Rochester Medical Center
Monroe Community Hospital
Rochester, NY

Lori Daiello, PharmD, ScM
Assistant Professor of Neurology
Warren Alpert Medical School
Assistant Professor of Health Services, Policy & Practice
Brown University School of Public Health
Portland, RI

Carolyn K. Clevenger, RN, DNP, AGPCNP-BC, GNP-BC, FAANP
Associate Dean for Clinical and Community Partnerships
Professor, Nell Hodgson Woodruff School of Nursing
Emory University Integrated Memory Care Clinic
Brain Health Center
Emory Healthcare
Atlanta, GA

Moderator:
Laeth Nasir, MBBS
Professor of Family Medicine
Associate Dean for Community Medicine
Creighton University
Omaha, NE

Credit Hours

ACCME: 1.0 AMA PRA Category 1 Credit
ACPE: 1.0 contact hour (0.10 CEU)
ANCC: 1.0 contact hour (which includes .25 hours of pharmacology credit)

Medium

Mobile + Online on Univadis

Program Description

Undertreatment and mistreatment of Alzheimer’s disease and its associated symptoms are significant health care problems. This multidisciplinary activity will examine effective management strategies and optimal therapy for cognitive and neuropsychiatric symptoms.

Program Developer/Facilitator


.

Target Audience

Physicians, advanced practice nurses, physician assistants, and consultant or senior care pharmacists who care for older adults.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Discuss currently-available agents for the management of the cognitive symptoms of Alzheimer’s disease.
  2. Develop strategies for managing agitation and depression in patients with Alzheimer’s disease.
  3. Describe agents in late-stage development for the prevention and management of Alzheimer’s disease.
  4. Incorporate collaborative care strategies to create a management plan for patients with Alzheimer’s disease.

Nursing Learning Outcome: After attending this session, the learner will be able to outline optimal treatment and management of Alzheimer’s disease.

Disclosures

Anton Porsteinsson, MD, discloses the following conflicts of interest.
Grant/research: AstraZeneca, Avanir, Biogen, Biohaven, Eisai, Lilly, Genentech/Roche, Janssen, Merck, Novartis
Consultant/advisory board: Acadia, Alzheon, Functional Neuromodulation, Neurim
Lori Daiello, PharmD, ScM, has no conflicts of interest to disclose.
Carolyn K. Clevenger, RN, DNP, AGPCNP-BC, GNP-BC, FAANP, has no conflicts of interest to disclose.
Laeth Nasir, MBBS, discloses that his spouse has served as a consultant for Pfizer Inc.
Susan P. Tyler, MEd, CMP, CHCP, CME Director, University of Cincinnati, has no conflicts of interest to disclose.
Bruce C. Gebhardt, MD, CME Reviewer-Compliance, University of Cincinnati, has no conflicts of interest to disclose.
Heather Muskopf, Program Manager, Continuing Medical Education, University of Cincinnati, has no conflicts of interest to disclose.
Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose.

The credit providers require all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Credit Statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release date: March 29, 2019
Last review date: March 29, 2019
Expiration date: March 29, 2020

ACCME Accreditation Support:
Please contact the University of Cincinnati Continuing Medical Education Department at uccme@uc.edu or call 513-558-7277.

The American Society of Consultant Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity, ACPE UAN 0203-9999-19-034-H01-P is approved for 1.0 contact hour. Participants must view the activity in its entirety, complete the post-test (80% or higher) and evaluation to receive CPE credit. Initial Release Date: March 29, 2019, Expiration Date: March 29, 2020.

This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA), the University of Cincinnati, the American Society of Consultant Pharmacists, and MCM Education.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.

Commercial Support Statements

This activity is supported by an educational grant from Biogen.

Instructions

Completion Instructions

  1. Accessing Activity:
    * Click "Start Program" and log into program on QuantiaMD.com
    * Take the pre-test
    * Review the activity
    * Take the post-test and score 80%
    * You are allowed a total of 3 attempts
    * Complete the evaluation
    * View, print, or save a CME certificate verifying your
    credit/participation in this activity
  2. Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

Certificate Fee

$0.00

There is no charge for CME/CPE/CNE credit.

Disclaimer

©2019 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the University of Cincinnati, ASCP, GAPNA, or Biogen. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS